IDEX CORP /DE/
(IEX)CIK 832101 · SEC filings only
shown as history
Dividend record — shown as history, not graded
A declared dividend is a reported fact, not a promise we grade. Here's the record — raises, holds, and cuts — each linked to its source filing.
Dividend record
17 declarations · 0 raised · 0 held · 0 cut
- NOTED$1.4600/shperiod ended 2026-06-30Filing ↗
- NOTED$0.7100/shperiod ended 2025-09-30Filing ↗
- NOTED$1.4200/shperiod ended 2025-06-30Filing ↗
- NOTED$0.6900/shperiod ended 2024-09-30Filing ↗
- NOTED$1.3800/shperiod ended 2024-06-30Filing ↗
- NOTED$0.6400/shperiod ended 2023-09-30Filing ↗
- NOTED$1.2800/shperiod ended 2023-06-30Filing ↗
- NOTED$0.6000/shperiod ended 2022-09-30Filing ↗
- NOTED$1.2000/shperiod ended 2022-06-30Filing ↗
- NOTED$0.5400/shperiod ended 2021-09-30Filing ↗
- NOTED$1.0800/shperiod ended 2021-06-30Filing ↗
- NOTED$0.5000/shperiod ended 2020-09-30Filing ↗
harness minimum not met
Sector median (Technology): A+ across 6 graded companies
Not enough resolved promises to grade
0 of the 4 resolved buyback promises needed to publish a reliability grade. Here's what we're tracking — we never show a grade we can't back with receipts.
buyback history
Free scorecards show the 12 most recent resolved buyback promises. See the complete multi-year record with Pro.
See Pro →Open promises (1)
Increased share repurchase authorization to $1 billion
grade
Sector median (Technology): A+ across 41 graded companies
Resolved promises
Full say-do history
Free scorecards show the 12 most recent resolved guidance promises. See the complete multi-year record with Pro.
See Pro →Guidance by basis
25 of 38 guidance figures that were graded or dropped for basis could not be graded on the same basis (66%). Guidance marked “not judged” is in neither number.
| Guidance type | Said | Graded | Dropped | Other |
|---|---|---|---|---|
| Revenue · non-GAAPcannot be graded | 2 | 0 | 2 | 0 |
| Revenue · basis not stated | 40 | 1 | 0 | 39 |
| EPS · GAAP | 19 | 12 | 0 | 7 |
| EPS · non-GAAPcannot be graded | 26 | 0 | 14 | 12 |
| EPS · basis not statedcannot be graded | 12 | 0 | 9 | 3 |
Said counts every revenue and EPS guidance figure on record. Dropped counts figures whose period was reported but which have no comparable GAAP actual in SEC XBRL. Other covers open, superseded, withdrawn and otherwise unresolved figures. The coverage note below counts every figure shown but not graded, including figures whose period has not been reported, so it can be larger.
Guidance shown, not graded (79)
We show what was said — with its source filing — but never score it. The line under each statement says why.
- eps guidance fy · Jul 29, 2026Full year adjusted diluted EPS of $8.70 to $8.85Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance fy · Jul 29, 2026Full year organic sales projected to increase 5% to 6% over the prior yearNot judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- eps guidance q · Jul 29, 2026Third quarter 2026 adjusted diluted EPS of $2.20 to $2.25Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance q · Jul 29, 2026Third quarter 2026 organic sales projected to increase 5% to 7% from the prior year periodNot judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- eps guidance fy · Apr 29, 2026Full year adjusted diluted EPS of $8.35 to $8.55Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance q · Apr 29, 2026Second quarter 2026 organic sales projected to increase 3% to 4% from the prior year periodNot judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- eps guidance q · Apr 29, 2026Second quarter 2026 adjusted diluted EPS of $2.07 to $2.12Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance fy · Apr 29, 2026Full year organic sales projected to increase 3% to 4% over the prior yearNot judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- eps guidance fy · Feb 4, 2026Full year adjusted diluted EPS of $8.15 to $8.35Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance q · Feb 4, 2026First quarter 2026 adjusted diluted EPS of $1.73 to $1.78Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance fy · Feb 4, 2026Full year organic sales projected to increase 1% to 2% over the prior yearNot judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- revenue guidance q · Feb 4, 2026First quarter 2026 organic sales projected to increase approximately 1% from the prior year periodNot judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- eps guidance fy · Oct 29, 2025Adjusted diluted EPS of $7.86 - $7.91Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Jul 30, 2025In 2025, the Company now expects to generate GAAP diluted EPS of $6.30 - $6.44Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance q · Jul 30, 2025expected third quarter 2025 organic sales growth of 2% to 3%Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- eps guidance q · Jul 30, 2025In the third quarter 2025, the Company expects to generate GAAP diluted EPS of $1.54 - $1.61Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance fy · May 1, 2025expected full year organic sales growth of 1% to 3%Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- revenue guidance q · May 1, 2025expected second quarter 2025 organic sales growth of 0% to 2%Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- eps guidance fy · Feb 4, 2025adjusted diluted EPS of $8.10 to $8.45Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance q · Feb 4, 2025First quarter 2025 organic sales are projected to decrease 3% to 4% from the prior year periodNot judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- revenue guidance fy · Feb 4, 2025Full year organic sales are projected to increase 1% to 3% over the prior yearNot judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- eps guidance q · Feb 4, 2025adjusted diluted EPS of $1.60 to $1.65Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance q · Oct 30, 2024Estimated adjusted diluted EPS attributable to IDEX $2.01 - $2.06Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance q · Oct 30, 2024Change in organic net sales 3 % 4 %Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- eps guidance fy · Oct 30, 2024Full year GAAP diluted EPS of $6.65 - $6.70Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance q · Oct 30, 2024Estimated diluted EPS attributable to IDEX $1.64 - $1.69Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Oct 30, 2024Adjusted diluted EPS of $7.85 - $7.90Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance q · Aug 1, 2024Third quarter organic sales are projected to be 0% to 1% over the prior year periodNot judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- revenue guidance fy · Aug 1, 2024Full year organic sales growth is projected to decline 1% to 2% versus the prior yearNot judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- revenue guidance q · Apr 24, 2024Second quarter organic sales are projected to decline 2% to 3% over the prior year periodNot judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- revenue guidance fy · Apr 24, 2024Full year organic sales growth is projected to be 0% to 2% over the prior yearNot judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- eps guidance q · Feb 7, 2024Earnings per Share Adjusted* $1.70 - $1.75Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance fy · Feb 7, 2024FY 2024 Guidance Range* $3,320 - $3,386Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- revenue guidance q · Feb 7, 2024FY 2024 Guidance Range* $3,320 - $3,386Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- eps guidance q · Oct 26, 2023adjusted diluted EPS of $1.74 - $1.79Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Oct 26, 2023adjusted diluted EPS of $8.13 - $8.18Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance q · Oct 26, 2023Fourth quarter 2023 organic sales are projected to decline 8% to 9% over the prior year periodNot judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- revenue guidance fy · Oct 26, 2023Full year 2023 organic sales are projected to decline 1% to 2% over the prior yearNot judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- revenue guidance fy · Jul 27, 2023Full year 2023 organic sales are projected to decline 1 to 2 percent over the prior yearNot judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- eps guidance q · Apr 27, 2023adjusted EPS of $2.10 to $2.13Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance fy · Apr 27, 2023Full year 2023 organic sales growth is projected to be 0 to 3 percent over the prior year periodNot judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- revenue guidance q · Apr 27, 2023Second quarter 2023 organic sales growth is projected to be approximately 3 percentNot judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- eps guidance fy · Apr 27, 2023adjusted EPS of $8.25 to $8.55Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Feb 1, 2023$8.50 - $8.80Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance fy · Feb 1, 2023FY 2023 Guidance Range* $3,345 - $3,461Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- eps guidance q · Feb 1, 2023Adjusted* $1.98 - 2.03Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance q · Feb 1, 2023FY 2023 Guidance Range* $3,345 - $3,461Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- revenue guidance fy · Oct 26, 2022Full year 2022 organic sales growth is projected to be approximately 12 percent over the prior year periodNot judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- eps guidance q · Oct 26, 2022fourth quarter 2022 reported EPS attributable to IDEX of $1.75 to $1.80Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Oct 26, 2022The Company expects full year 2022 reported EPS attributable to IDEX of $7.75 to $7.80Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance q · Jul 27, 2022a 9 to 10 percent organic sales increase in the third quarter of 2022Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- revenue guidance fy · Jul 27, 2022Full year 2022 organic sales growth is projected to be approximately 10 percentNot judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- eps guidance q · Apr 27, 2022Estimated adjusted EPS attributable to IDEX $1.85 - $1.90Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance fy · Apr 27, 2022Full year 2022 organic sales growth is projected to be 6 to 8 percentNot judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- eps guidance q · Apr 27, 2022second quarter 2022 reported EPS attributable to IDEX of $1.69 to $1.74Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance q · Apr 27, 2022an 8 to 9 percent organic sales increase in the second quarter of 2022Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- eps guidance fy · Apr 27, 2022adjusted EPS attributable to IDEX of $7.50 to $7.63Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Apr 27, 2022The Company expects full year 2022 reported EPS attributable to IDEX of $6.87 to $7.00Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance fy · Feb 2, 2022Organic sales growth is projected to be 5 to 8 percent for 2022Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- revenue guidance q · Feb 2, 2022a 6 to 7 percent organic sales increase in the first quarter of 2022Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- eps guidance q · Oct 27, 2021EPS in the range of $1.55 to $1.58Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Oct 27, 2021narrowing our adjusted EPS range to $6.30 to $6.33Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance q · Oct 27, 2021we expect organic sales growth of 9 to 10 percentNot judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- revenue guidance fy · Oct 27, 2021maintaining our projection of 11 to 12 percent organic sales growthNot judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- revenue guidance q · Jul 28, 2021a 14 to 16 percent organic sales increase in the third quarterUnverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance fy · Jul 28, 2021we are now projecting 11 to 12 percent organic sales growth for the full year 2021Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Jul 28, 2021Full year 2021 adjusted EPS is now projected to be $6.26 to $6.36Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance q · Jul 28, 2021third quarter adjusted EPS of $1.57 to $1.61Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance fy · Apr 28, 2021raising our full year adjusted EPS guidance to $6.05 to $6.20Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance q · Apr 28, 2021second quarter adjusted EPS of $1.60 to $1.63Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- eps guidance q · Feb 4, 2021with first quarter EPS of $1.38 to $1.42Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance fy · Feb 4, 2021We are projecting 6 to 8 percent organic sales growth for the full year 2021Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- revenue guidance q · Feb 4, 2021with a 2 to 4 percent organic sales increase in the first quarterNot judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- eps guidance fy · Feb 4, 2021Full year 2021 EPS is projected to be $5.65 to $5.95Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance q · Oct 28, 2020we expect fourth quarter organic sales to continue to improve sequentially and be down approximately 3 to 5 percent versus prior yearNot judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- revenue guidance q · Jul 24, 2020we now expect third quarter organic sales to be down approximately 12 to 17 percent versus prior yearNot judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- eps guidance fy · Jan 30, 2019Full year 2019 EPS is expected to be in the range of $5.60 to $5.80Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
- revenue guidance fy · Jan 30, 2019we are projecting 4 to 5 percent organic revenue growth in 2019Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
- eps guidance q · Jan 30, 2019first quarter EPS in the range of $1.35 to $1.38Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
Open promises (1) · 6 superseded
GAAP diluted EPS of $1.50 - $1.55
We expect full year 2022 GAAP EPS of $6.70 to $7.00
GAAP EPS of $7.30 to $7.60
Full year GAAP diluted EPS of $7.13 - $7.43
Full year GAAP diluted EPS of $6.56 to $6.96
GAAP EPS of $6.80 - $6.90
the Company expects to generate GAAP diluted EPS of $6.56 - $6.95
Credibility timeline
Timeline as a list
- Apr 27, 2022ABOVEfirst quarter 2022 GAAP EPS of $1.57 to $1.60
- Oct 26, 2022ABOVEthird quarter 2022 reported EPS attributable to IDEX of $1.80 to $1.85
- Feb 23, 2023ABOVEfull year 2022 reported EPS attributable to IDEX of $7.19 to $7.29
- Jul 27, 2023BELOWGAAP EPS of $1.86 to $1.89
- Oct 26, 2023ABOVEGAAP EPS of $1.60 - $1.65
- Feb 22, 2024BELOWGAAP diluted EPS of $7.91 - $7.96
- Aug 1, 2024ABOVESecond quarter GAAP diluted EPS of $1.75 - $1.80
- Oct 30, 2024BELOWThird quarter GAAP diluted EPS of $1.61 - $1.66
- Feb 20, 2025BELOWFull year GAAP diluted EPS of $6.85 - $6.95
- May 1, 2025ABOVEFirst quarter GAAP diluted EPS of $1.18 to $1.24
- Jul 30, 2025ABOVEthe Company expects to generate GAAP diluted EPS of $1.60 - $1.72
- Feb 19, 2026ABOVEGAAP diluted EPS of $6.35 - $6.40